These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37670696)
1. Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway. Jiang J; Zhang C; Wang J; Zhu Y; Wang X; Mao P Anticancer Agents Med Chem; 2023; 23(19):2127-2134. PubMed ID: 37670696 [TBL] [Abstract][Full Text] [Related]
2. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299 [TBL] [Abstract][Full Text] [Related]
3. LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway. Guo JL; Tang T; Li JH; Yang YH; Zhang L; Quan Y Pathol Oncol Res; 2020 Jul; 26(3):1757-1766. PubMed ID: 31650338 [TBL] [Abstract][Full Text] [Related]
4. Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway. Qu J; Sun Y; Yang L; Niu X; Li L J Biochem Mol Toxicol; 2022 Jun; 36(6):e23027. PubMed ID: 35266250 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells. Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187 [TBL] [Abstract][Full Text] [Related]
6. SMC4 knockdown inhibits malignant biological behaviors of endometrial cancer cells by regulation of FoxO1 activity. Yan Y; Liu C; Zhang J; Li W; Yin X; Dong L; Pang S; Li X Arch Biochem Biophys; 2021 Nov; 712():109026. PubMed ID: 34506757 [TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells. Tanaka T; Toujima S; Tanaka J Int J Oncol; 2012 Nov; 41(5):1837-44. PubMed ID: 22923148 [TBL] [Abstract][Full Text] [Related]
8. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway. Li G; Xu D; Sun J; Zhao S; Zheng D Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway. Sun X; Xing G; Zhang C; Lu K; Wang Y; He X Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350 [TBL] [Abstract][Full Text] [Related]
11. Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer O'Donnell J; Zhao Z; Buckingham L; Hao T; Suo H; Zhang X; Fan Y; John C; Deng B; Shen X; Sun W; Secord AA; Zhou C; Bae-Jump VL Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503790 [TBL] [Abstract][Full Text] [Related]
12. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR. Zhang S; Wang M; Li Q; Zhu P Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412 [TBL] [Abstract][Full Text] [Related]
13. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma. Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667 [TBL] [Abstract][Full Text] [Related]
14. CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling. Zhang X; Xu Q; Li E; Shi T; Chen H Mol Cell Biochem; 2023 Jul; 478(7):1561-1571. PubMed ID: 36434144 [TBL] [Abstract][Full Text] [Related]
15. Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway. Li J; Zhang Z; Hu Y; Wei Q; Shao X Anticancer Drugs; 2022 Oct; 33(9):883-892. PubMed ID: 36136988 [TBL] [Abstract][Full Text] [Related]
16. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells. Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970 [TBL] [Abstract][Full Text] [Related]
17. MiR-196a-5p facilitates progression of estrogen-dependent endometrial cancer by regulating FOXO1. Zhu Y; Tang Y; Fan Y; Wu D Histol Histopathol; 2023 Oct; 38(10):1157-1168. PubMed ID: 36573636 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways. Li Z; Min W; Gou J Cancer Chemother Pharmacol; 2013 Nov; 72(5):1001-11. PubMed ID: 24036847 [TBL] [Abstract][Full Text] [Related]
19. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer. Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway. Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]